|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Varughese E, Kondalsamy-Chennakesavan S
and Obermair A: The value of serum CA125 for the development of
virtual follow-up strategies for patients with epithelial ovarian
cancer: A retrospective study. J Ovarian Res. 5:112012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Givens V, Mitchell GE, Harraway-Smith C,
Reddy A and Maness DL: Diagnosis and management of adnexal masses.
Am Fam Physician. 80:815–820. 2009.PubMed/NCBI
|
|
4
|
Schummer M, Drescher C, Forrest R, Gough
S, Thorpe J, Hellström I, Hellström KE and Urban N: Evaluation of
ovarian cancer remission markers HE4, MMP7 and Mesothelin by
comparison to the established marker CA125. Gynecol Oncol.
125:65–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He C, Qiao H, Jiang H and Sun X: The
inhibitory role of b7-h4 in antitumor immunity: association with
cancer progression and survival. Clin Dev Immunol. 2011:6958342011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mao Y, Li W, Chen K, Xie Y, Liu Q, Yao M,
Duan W, Zhou X, Liang R and Tao M: B7-H1 and B7-H3 are independent
predictors of poor prognosis in patients with non-small cell lung
cancer. Oncotarget. 6:3452–3461. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao LW, Li C, Zhang RL, Xue HG, Zhang FX,
Zhang F and Gai XD: B7-H1 and B7-H4 expression in colorectal
carcinoma: Correlation with tumor FOXP3(+) regulatory T-cell
infiltration. Acta Histochem. 116:1163–1168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Topalian SL, Drake CG and Pardoll DM:
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor
immunity. Curr Opin Immunol. 24:207–212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang X, Wang T, Xu M, Xiao L, Luo Y, Huang
W, Zhang Y and Geng W: B7-H4 overexpression impairs the immune
response of T cells in human cervical carcinomas. Hum Immunol.
75:1203–1209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song X, Liu J, Lu Y, Jin H and Huang D:
Overexpression of B7-H1 correlates with malignant cell
proliferation in pancreatic cancer. Oncol Rep. 31:1191–1198.
2014.PubMed/NCBI
|
|
11
|
Yu XW, Li CH, Zhang SL, et al: Study on
the expression of PD-L1 in patients with ovarian cancer. Chin J Lab
Diagn. 14:1854–1856. 2010.
|
|
12
|
Wu C, Zhu Y, Jiang J, Zhao J, Zhang XG and
Xu N: Immunohistochemical localization of programmed death-1
ligand-1 (PD-L1) in gastric carcinoma and its clinical
significance. Acta Histochem. 108:19–24. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hamanishi J, Mandai M, Iwasaki M, Okazaki
T, Tanaka Y, Yamaguchi K, Higuchi T, Yagi H, Takakura K, Minato N,
et al: Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+
T lymphocytes are prognostic factors of human ovarian cancer. Proc
Natl Acad Sci USA. 104:3360–3365. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salceda S, Tang T, Kmet M, Munteanu A,
Ghosh M, Macina R, Liu W, Pilkington G and Papkoff J: The
immunomodulatory protein B7-H4 is overexpressed in breast and
ovarian cancers and promotes epithelial cell transformation. Exp
Cell Res. 306:128–141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tringler B, Liu W, Corral L, Torkko KC,
Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J and Shroyer
KR: B7-H4 overexpression in ovarian tumors. Gynecol Oncol.
100:44–52. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang N, Fang P and Gu ZJ: Preparation and
characterization of monoclonal antibody against human B7-H4
molecule. Monoclon Antib Immunodiagn Immunother. 33:270–274. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sznol M: Blockade of the B7-H1/PD-1
pathway as a basis for combination anticancer therapy. Cancer J.
20:290–295. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Afreen S and Dermime S: The
immunoinhibitory B7-H1 molecule as a potential target in cancer:
Killing many birds with one stone. Hematol Oncol Stem Cell Ther.
7:1–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qian Y, Hong B, Shen L, Wu Z, Yao H and
Zhang L: B7-H4 enhances oncogenicity and inhibits apoptosis in
pancreatic cancer cells. Cell Tissue Res. 353:139–151. 2013.
View Article : Google Scholar : PubMed/NCBI
|
